Vascular deterioration in cirrhosis - The big picture

被引:107
作者
Bosch, Jaime
机构
[1] Univ Barcelona, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Hepat Hemodynam Lab, Liver Unit,Hosp Clin, E-08036 Barcelona, Spain
[2] Ctr Invest Biomed Enfermedades Hepat & Digest, Barcelona, Spain
关键词
portal hypertension; variceal bleeding;
D O I
10.1097/MCG.0b013e3181572357
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Cirrhosis is characterized by marked abnormalities in the hepatic circulation. Functionally, there is an increased vascular tone and impaired flow-mediated vasorelaxation, whereas anatomically there is sinusoidal remodeling and capillarization, angiogenesis, venous thrombosis, and vascular distortion, all contributing to increase hepatic vascular resistance and portal hypertension. However, vascular changes are not limited to the liver, but are also present in the splanchnic organs, heart, lungs, kidney, brain, and skin. Advances in the knowledge of the mechanisms of these abnormalities have disclosed new targets for therapy and ultimately improved survival.
引用
收藏
页码:S247 / S253
页数:7
相关论文
共 49 条
[1]   Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis [J].
Abraldes, JG ;
Tarantino, I ;
Turnes, J ;
Garcia-Pagan, JC ;
Rodés, J ;
Bosch, J .
HEPATOLOGY, 2003, 37 (04) :902-908
[2]   NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats [J].
Angermayr, Bernhard ;
Fernandez, Mercedes ;
Mejias, Marc ;
Gracia-Sancho, Jorge ;
Garcia-Pagan, Juan Carlos ;
Bosch, Jaime .
GUT, 2007, 56 (04) :560-564
[3]   Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management [J].
Arroyo, V ;
Colmenero, J .
JOURNAL OF HEPATOLOGY, 2003, 38 :S69-S89
[4]   Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II [J].
Bataller, R ;
Sancho-Bru, P ;
Ginès, P ;
Lora, JM ;
Al-Garawi, A ;
Solé, M ;
Colmenero, J ;
Nicolás, JM ;
Jiménez, W ;
Weich, N ;
Gutiérrez-Ramos, JC ;
Arroyo, V ;
Rodés, J .
GASTROENTEROLOGY, 2003, 125 (01) :117-125
[5]  
BOSCH J, 1988, Z GASTROENTEROL, V26, P8
[6]   Prevention of variceal rebleeding [J].
Bosch, J ;
García-Pagán, JC .
LANCET, 2003, 361 (9361) :952-954
[7]   Current management of portal hypertension [J].
Bosch, J ;
Abraldes, JG ;
Groszmann, R .
JOURNAL OF HEPATOLOGY, 2003, 38 :S54-S68
[8]   Measurement of portal pressure and its role in the management of chronic liver disease [J].
Bosch, Jaime ;
Garcia-Pagan, Juan Carlos ;
Berzigotti, Annalisa ;
Abraldes, Juan G. .
SEMINARS IN LIVER DISEASE, 2006, 26 (04) :348-362
[9]   Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation:: A randomized controlled study [J].
Carrion, Jose A. ;
Navasa, Miquel ;
Garcia-Retortillo, Montserrat ;
Garcia-Pagan, Juan Carlos ;
Crespo, Gonzalo ;
Bruguera, Miquel ;
Bosch, Jaime ;
Forns, Xavier .
GASTROENTEROLOGY, 2007, 132 (05) :1746-1756
[10]   Clinical events after transjugular intrahepatic portosystemic shunt:: Correlation with hemodynamic findings [J].
Casado, M ;
Bosch, J ;
García-Pagán, JC ;
Bru, C ;
Bañares, R ;
Bandi, JC ;
Escorsell, A ;
Rodríguez-Láiz, JM ;
Gilabert, R ;
Feu, F ;
Schorlemer, C ;
Echenagusia, A ;
Rodés, J .
GASTROENTEROLOGY, 1998, 114 (06) :1296-1303